Macrolide resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002;1999-2000 Ve 2001-2002 yillarina ai̇t grup A beta hemoli̇ti̇k streptokok i̇zolatlarinin makroli̇d anti̇bi̇yoti̇klere di̇renç oranlari ve fenoti̇pleri̇

Mikrobiyoloji Bulteni

Volumn 37, Issue 4, 2003, Pages 225-234

  Şenses, Zeynep ^a   Baysallar, Mehmet ^a   Gür, Deniz ^b   Doǧanci, Levent ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Group A beta hemolytic streptococcus; Macrolide resistance

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL PROTOCOL; DIAGNOSTIC TEST; E TEST; EPIDEMIOLOGICAL DATA; GEOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRACTICE GUIDELINE; STATISTICAL ANALYSIS; STREPTOCOCCUS GROUP A;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PHARYNX; PHENOTYPE; STREPTOCOCCUS PYOGENES;

EID: 0346501925     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Goossens H, Sprenger MJ: Community aquired infections and bacterial resistance. BMJ 1998, 317: 654-657.
2. Hansman D: Chemotherapy of streptococcal infections; Implications of antimicrobial drug resistance in Streptococcus pyogenes. Med J Australia 1989, 150: 611-612.
3. Wittler RR, Yamada SM, Bass JW, Hamil R: Penicillin tolerance and erythromycin resistance of group A beta-hemolytic streptococci in Hawaii and the Philippines. AJDC 1990, 144: 587-589.
4. Borzani M, Luca MD, Varotto F: A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy. J Antimicrob Chemother 1997, 40: 457-458.
5. Holmström L, Nyman B, Rosengren M, Wallander S, Ripa T: Outbreaks of infections with erythromycin-resistant group-A streptococci in child day care centres. Scand J Infect Dis 1990, 22: 179-185.
6. Phillips G, Parratt D, Orange GV, Harper I, McEwan H, Young N: Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother 1990, 25: 723-724.
7. Rolston KV, Ho DH, Le Blanc B, Bodey GP: Comparative in vitro activity of the new erythromycin derivative dirithromycin against Gram-positive bacteria isolated from cancer patients. Eur J Clin Microbiol Inf Dis 1990, 1: 30-33.
8. National Committee for Clinical Laboratory Standards: Streptococcus spp. other than S.pneumoniae. M02-M07 Bundle, Table 2H. 2000, NCCLS, Wayne, Pa.
9. Garcia-Bermejo I, Cacho J, Orden B, Alos JI, Gomez-Garces JL: Emergence of erythromycin resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. Antimicrob Agents Chemother 1998, 42: 989-990.
10. Weisblum B: Inducible resistance to macrolides, lincosamides and streptogramin type b antibiotics: The resistance phenotype, its biological diversity, and structural elements that regulate expression - A review. J Antimicrob Chemother 1985, 16 (Suppl A): 63-90.
11. De Azavedo JCS, Yeung RH, Bast DJ, Duncan CL, Borgia SB, Low DE: Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother 1999, 43: 2144-2148.
12. Baran D, Cordier N: Evaluation of clindamycin in group A beta haemolytic streptococcal infections in children. Acta Pediatr Belg 1973, 27: 329-333.
13. Kaplan EL: Recent evaluation of antimicrobial resistance in beta-hemolytic streptococci. Clin Infect Dis 1997, 24 (Suppl 1): 89-92.
14. Kaplan EL: The resurgence of group A streptococcal infections and their sequeale. Eur J Clin Microbiol Inf Dis 1991, 10: 55-57.
15. Zackrisson G, Lind L, Roos K, Larsson P: Erythromycin resistant beta-hemolytic streptococci group A in Goteborg, Sweden. Scand J Inf Dis 1988, 20: 419-420.
16. Bass JW, Weisse ME, Plymyer MR, Murphy S, Eberly BJ: Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan. Arch Pediatr Adolesc Med 1994, 48: 67-71.
17. Cocuzza C, Blandino G, Mattina R, Nicoletti F, Nicoletti G: Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania. Microb Drug Resist 1997, 3: 379-384.
18. Järvinen H, Nissinen A, Huovinen P: Erythromycin resistance in group A streptococci. Lancet 1989, 1022-1023.
19. Rahal K, Wanng F, Schindler C, et al: Reports on surveillance of antimicrobial resistance in individual countries. Clin Infect Dis 1997, 24: 169-175.
20. Scott RJ, Naidoo J, Lightfoot NF, George RC: A community outbreak of group A haemolytic streptococci with transferable resistance to erythromycin. Epidemiol Infect 1989, 102: 85-91.
21. Spencer RC, Wheat PF, Magea JT, Brown EH: Erythromycin resistance in streptococci. Lancet 1989, i: 168-169.
22. Berkiten R, Bal Ç, Altun B: Onüç yillik bir sürede A grubu streptokoklar için penisilin G ve eritromisin MİK deǧerlerindeki deǧişmeler. Ankem Derg 1996, 10: 367-373.
23. Berkiten R, Erdeniz H: 1970'li yillarla 1995 yilinda izole edilen grup A streptokoklarda penisilin G ve eritromisinin MİK deǧerleri. Ankem Derg 1997, 11: 19-22.
24. Ergüven S, Gür D, Akalin HE, Berkman E: Basitrasine duyarli beta-hemolitik streptokoklarin eritromisin, roksitromisin ve klindamisine in vitro duyarliliklari. İnfeks Derg 1990, 4: 401-405.
25. Türet S, Karabiber N: A grubu beta hemolitik streptokoklarda penisilin G ve eritromisin duyarliliǧi. Ankem Derg 1990, 4: 202.
26. Gürsoy G, Çöplü N, Zarakolu P, Ulumlu G, Özkaya E, Güvener E: A grubu beta-hemolitik streptokoklarin antimikrobiklere in-vitro duyarliliklari. Ankem Derg 1993, 72: 83.
27. Öncül Ö, Aktepe OC, Gözalan A, Güvener E: A grubu beta-hemolitik streptokoklarda eritromisin direnci. Ankem Derg 1995, 9: 111.
28. Göksel S, Tünger A, Çavuşoǧlu C, Özkan F, Özinel MA: A grubu beta hemolitik streptokoklarda eritromisin duyarliliǧi. XVIII. Türk Mikrobiyoloji Kongresi, 4-9 Ekim 1998, Antalya. Poster No: 12-176.
29. Karabiber N, Karahan M, Kiliç H: A grubu beta-hemolitik streptokoklarda penisilin G ve eritromisin duyarliliǧi. Ankem Derg 1998, 12: 111.
30. Köksalan H, Beri S, Mert A: Grup A beta hemolitik streptokoklarin antibiyotik duyarliliklarinin belirlenmesi. Ankem Derg 1992, 6: 157.
31. Kaptanoǧlu S, Kaya AD, Şengül M, Kiraz N: Grup A streptokoklarin bazi antimikrobiyallere duyarliliklari. Ankem Derg 1995, 9: 110.
32. Barry AL, Jones RN, Thornsberry C: In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268,TE-031), erythromycin, roxithromycin, and clindamycin. Antimicrob Agents Chemother 1988, 32: 752-754.
33. Esposito S, Noviello S, Ianniello F, D'errico G: Erythromycin resistance in group A beta hemolytic streptococcus. Chemother 1988, 44: 385-390.
34. Tunçkanat F, Şener B, Akan Ö, Berkman E: A grubu beta-hemolitik streptokoklara bazi makrolid antibiyotiklerinin in-vitro etkileri. Ankem Derg 1993, 7: 51.
35. Özen M, Onat N, Koç S, Ak Ç, Duman A: A grubu beta-hemolitik streptokoksik anjinlerde penisilin ve azitromisin tedavisine olan yanitin karşilaştirilmasi. Ankem Derg 1995, 9: 181.
36. Aynaci FM, Mocan H, Soylu H, Aydin K, Köksal I: Çocukluk yaş grubunda beta-hemolitik streptokoklara baǧli akut tonsillit tedavisinde azitromisin, eritromisin ve benzatin penisilin etkinliklerinin karşilaştirilmasi. Ankem Derg 1997, 11: 14-18.
37. Arslantürk A, Yousefi Rad A, Akdenizli MA: Boǧaz kültürlerinden izole edilen beta-hemolitik streptokoklarin azitromisin'e direnç durumlari. XVIII. Türk Mikrobiyoloji Kongresi, 4-9 Ekim 1998. Antalya. Poster No: 12-177.
38. Durmaz B, Otlu B, Alibey E: Streptokoklarin makrolidlere ve penisilinlere duyarliliǧinin karşilaştirilmasi. XVIII. Türk Mikrobiyoloji Kongresi, 4-9 Ekim 1998, Antalya. Poster No: 12-173.
39. Calia FM, Oldach DW: Macrolide (and azalide) antibiotics: Erythromycin, azithromycin, clarithromycin, and dirithromycin, pp: 242-259. In: Gorbach SL, Bartlett JG, Blacklow NL (Eds), Infectious Diseases. 1998, WB Saunders Company, USA.